Age doesn't affect survival outcomes in patients with MDS who receive a HCT

A prospective study shows age doesn't affect survival outcomes in patients with myelodysplastic syndrome (MDS) who receive a hematopoietic cell transplant.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1QpUTnn